Blood Cancer Journal (Jun 2023)
Monitoring measurable residual disease and chimerism in patients with JAK2 V617F-positive myelofibrosis after allogeneic hematopoietic cell transplantation
Abstract
No abstracts available.
Blood Cancer Journal (Jun 2023)